BKA Wealth Consulting Inc. Invests $311,000 in Nutrien Ltd. (NYSE:NTR)

BKA Wealth Consulting Inc. bought a new position in Nutrien Ltd. (NYSE:NTR) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 5,515 shares of the company’s stock, valued at approximately $311,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Townsend & Associates Inc lifted its holdings in shares of Nutrien by 27.8% in the 3rd quarter. Townsend & Associates Inc now owns 163,942 shares of the company’s stock valued at $10,125,000 after acquiring an additional 35,690 shares during the last quarter. CIBC Asset Management Inc raised its position in Nutrien by 2.5% in the 3rd quarter. CIBC Asset Management Inc now owns 6,361,084 shares of the company’s stock worth $394,047,000 after purchasing an additional 154,159 shares during the period. Canoe Financial LP raised its position in Nutrien by 64.6% in the 3rd quarter. Canoe Financial LP now owns 75,945 shares of the company’s stock worth $4,690,000 after purchasing an additional 29,819 shares during the period. International Assets Investment Management LLC purchased a new stake in Nutrien in the 4th quarter worth about $3,433,000. Finally, First Eagle Investment Management LLC raised its position in Nutrien by 0.5% in the 3rd quarter. First Eagle Investment Management LLC now owns 9,262,659 shares of the company’s stock worth $572,062,000 after purchasing an additional 48,230 shares during the period. Institutional investors own 63.10% of the company’s stock.

Nutrien Stock Performance

NYSE:NTR traded down $0.75 during trading hours on Thursday, reaching $51.54. 301,594 shares of the company’s stock were exchanged, compared to its average volume of 1,981,166. The firm has a market capitalization of $25.49 billion, a price-to-earnings ratio of 20.46, a P/E/G ratio of 1.95 and a beta of 0.89. The company has a 50-day moving average of $53.17 and a 200 day moving average of $54.16. The company has a quick ratio of 0.65, a current ratio of 1.17 and a debt-to-equity ratio of 0.35. Nutrien Ltd. has a 1-year low of $47.90 and a 1-year high of $70.07.

Nutrien (NYSE:NTR) last released its earnings results on Wednesday, February 21st. The company reported $0.37 EPS for the quarter, missing the consensus estimate of $0.72 by ($0.35). Nutrien had a return on equity of 8.59% and a net margin of 4.33%. The firm had revenue of $5.66 billion during the quarter, compared to analyst estimates of $5.36 billion. During the same quarter last year, the business posted $2.02 EPS. The firm’s revenue was down 24.8% on a year-over-year basis. Research analysts anticipate that Nutrien Ltd. will post 3.82 EPS for the current year.

Nutrien Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, April 11th. Stockholders of record on Thursday, March 28th were paid a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 4.19%. The ex-dividend date of this dividend was Wednesday, March 27th. This is a boost from Nutrien’s previous quarterly dividend of $0.53. Nutrien’s dividend payout ratio (DPR) is 85.38%.

Analyst Ratings Changes

NTR has been the topic of a number of recent analyst reports. Royal Bank of Canada reduced their price objective on shares of Nutrien from $75.00 to $70.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. The Goldman Sachs Group cut their price objective on shares of Nutrien from $88.00 to $78.00 and set a “buy” rating on the stock in a report on Thursday, February 1st. Wolfe Research began coverage on shares of Nutrien in a report on Friday, March 1st. They set an “outperform” rating and a $66.00 price objective on the stock. HSBC lowered their target price on shares of Nutrien from $63.00 to $57.00 and set a “hold” rating for the company in a research note on Friday, March 8th. Finally, BMO Capital Markets lowered their price objective on shares of Nutrien from $86.00 to $80.00 and set an “outperform” rating for the company in a research note on Thursday, January 25th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $67.95.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.